SCHEMBL9259079

SCHEMBL9259079

Fc1ccc2c(c1)-c1ncnn1Cc1c(-c3nc(C4CC4)no3)ncn1-2

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRG2 P18507 15/20 0.66
GABRB3 P28472 15/20 0.66
GABRA5 P31644 15/20 0.66
GABRA1 P14867 2/20 0.51
GABRA3 P34903 2/20 0.51
GABRA2 P47869 2/20 0.51
GABRP O00591 1/20 0.51
GABRD O14764 1/20 0.51
GABRB1 P18505 1/20 0.51
GRM5 P41594 1/20 0.51
GABRB2 P47870 1/20 0.51
GABRA4 P48169 1/20 0.51
GABRE P78334 1/20 0.51
GABRA6 Q16445 1/20 0.51
GABRG1 Q8N1C3 1/20 0.51
GABRG3 Q99928 1/20 0.51
GABRQ Q9UN88 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9266435 0.90 GABRG2 (0.59) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9268520 0.89 GABRG2 (0.65) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9258726 0.87 GABRG2 (0.55) GABRG2GABRB3GABRA5
SCHEMBL6862817 0.86 GABRG2 (0.50) GABRG2GABRB3GABRA5
SCHEMBL9263697 0.86 GABRG2 (0.48) GABRG2GABRB3GABRA5
SCHEMBL9259917 0.84 GABRG2 (0.77) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9268266 0.81 GABRG2 (0.62) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9371304 0.81 GABRP (0.50) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9265109 0.80 GABRG2 (0.41) GABRG2GABRB3GABRA5GABRA1GABRA3
SCHEMBL9268188 0.80 GABRG2 (0.63) GABRG2GABRB3GABRA5GABRA1GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US claimed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP claimed
US-5387585-A Treating epilepsy, anxiety, sleep disorders, schizophrnia, senile dementia HOFFMANN-LA ROCHE INC. (US) 1995-02-07 US disclosed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP disclosed